Beijing Foyou Pharma CO.,LTD (SHA:601089)
China · Delayed Price · Currency is CNY 20.64
-0.23 (-1.10%)
At close: Apr 28, 2026
SHA:601089 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 434.14 | 469.36 | 488.67 | 488.77 | 438.9 | 314.47 |
Depreciation & Amortization | 128.37 | 128.37 | 101.97 | 97.76 | 82.85 | 63.25 |
Other Amortization | 9.27 | 9.27 | 5.19 | 7.03 | 1.24 | 0.23 |
Loss (Gain) From Sale of Assets | -0.02 | -0.02 | -1.04 | 1 | -0.14 | -0.01 |
Asset Writedown & Restructuring Costs | 0.04 | 0.04 | 2.75 | - | 0.8 | 1.13 |
Loss (Gain) From Sale of Investments | -17.76 | -17.76 | -11.19 | -2.28 | -3.17 | -2.36 |
Provision & Write-off of Bad Debts | 3.17 | 3.17 | 0.72 | -3.48 | 2.08 | -2.53 |
Other Operating Activities | 34.71 | 19.68 | 18.21 | 23.24 | 17.33 | 20.1 |
Change in Accounts Receivable | -127.89 | -127.89 | -28.57 | -23.28 | -68.65 | 5.59 |
Change in Inventory | -81.6 | -81.6 | -50.82 | 17.99 | -25.64 | -56.56 |
Change in Accounts Payable | -46.56 | -46.56 | 169.62 | -49.36 | 216.44 | 175.07 |
Change in Other Net Operating Assets | -0.58 | -0.58 | -1.36 | -2.76 | -3.84 | -0.27 |
Operating Cash Flow | 340.66 | 360.85 | 690.75 | 555.9 | 659.76 | 528.02 |
Operating Cash Flow Growth | -49.37% | -47.76% | 24.26% | -15.74% | 24.95% | 36.56% |
Capital Expenditures | -199.89 | -397.41 | -391.52 | -366.08 | -135.4 | -192.97 |
Sale of Property, Plant & Equipment | 0.88 | 0.89 | 1.37 | 0.52 | 0.63 | 0.27 |
Investment in Securities | 210.2 | 230.2 | -1,659 | - | 100 | -50 |
Other Investing Activities | -498.2 | 18.82 | 34.56 | -20.1 | 3.37 | 2.56 |
Investing Cash Flow | -487.01 | -147.5 | -2,015 | -385.66 | -31.41 | -240.14 |
Long-Term Debt Issued | - | - | 49.9 | 55 | 50.45 | 214.27 |
Long-Term Debt Repaid | - | -58.89 | -104.01 | -67.09 | -89.33 | -221.2 |
Net Debt Issued (Repaid) | -28.89 | -58.89 | -54.11 | -12.09 | -38.89 | -6.92 |
Issuance of Common Stock | - | - | - | - | 1,669 | - |
Repurchase of Common Stock | - | - | -176.19 | - | - | - |
Common Dividends Paid | -234.06 | -234.24 | -236.59 | -194.6 | -111.22 | -114.21 |
Other Financing Activities | 0.29 | 0.07 | -0.02 | - | -25.18 | -18.3 |
Financing Cash Flow | -262.67 | -293.07 | -466.9 | -206.68 | 1,494 | -139.44 |
Net Cash Flow | -409.01 | -79.71 | -1,791 | -36.44 | 2,123 | 148.44 |
Free Cash Flow | 140.77 | -36.55 | 299.23 | 189.82 | 524.36 | 335.05 |
Free Cash Flow Growth | -9.20% | - | 57.63% | -63.80% | 56.50% | 53.91% |
Free Cash Flow Margin | 4.04% | -1.04% | 8.68% | 5.68% | 16.18% | 11.81% |
Free Cash Flow Per Share | 0.30 | -0.08 | 0.64 | 0.40 | 1.24 | 0.93 |
Cash Income Tax Paid | 348.7 | 350.01 | 311.55 | 377.29 | 310.75 | 280.1 |
Levered Free Cash Flow | -44.8 | -214.98 | 195.38 | -3.46 | 342.84 | 274.68 |
Unlevered Free Cash Flow | -44.14 | -214 | 197.57 | -0.12 | 345.82 | 278.74 |
Change in Working Capital | -251.26 | -251.26 | 85.48 | -56.13 | 119.88 | 133.74 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.